Performance of VITEK 2, E-test, Kirby-Bauer disk diffusion, and modified Kirby-Bauer disk diffusion compared to reference broth microdilution for testing tigecycline susceptibility of carbapenem-resistant K. pneumoniae and A. baumannii in a multicenter study in China

Eur J Clin Microbiol Infect Dis. 2021 Jun;40(6):1149-1154. doi: 10.1007/s10096-020-04123-z. Epub 2021 Jan 7.

Abstract

Tigecycline is an alternative antibiotic for managing carbapenem-resistant Gram-negative bacterial infections. However, disk diffusion and automated testing often show false-intermediate or false-resistant results in tigecycline susceptibility, misleading clinical antimicrobial therapy. Broth microdilution (BMD) is the reference method for testing tigecycline susceptibility, but it is labor intensive and time consuming to perform in clinical laboratories. Therefore, a simple and accurate method is urgently needed. We evaluated the performance of VITEK 2, E-test, Kirby-Bauer disk diffusion (KB), and modified KB disk diffusion (mKB) versus BMD in testing tigecycline susceptibility of 372 strains of carbapenem-resistant Klebsiella pneumoniae (CRKP) and 346 strains of carbapenem-resistant Acinetobacter baumannii (CRAB). BMD confirmed that 96.8% of CRKP and 91% of CRAB strains were susceptible to tigecycline. E-test, VITEK 2, KB, and mKB yielded categorical agreement of 96.7/59.3%, 69.9/54.3%, 78.5/87.3%, and 96.5%/91% for CRKP/CRAB, respectively. No very major error was found for either CRKP or CRAB by any method. No major error was found for CRKP or CRAB by the mKB method. The mKB method enhanced by R-buffer is simple, accurate, and inexpensive for clinical laboratories to test the susceptibility of CRKP and CRAB isolates to tigecycline.

Keywords: Antimicrobial susceptibility testing; Carbapenem-resistant Acinetobacter baumannii; Carbapenem-resistant Klebsiella pneumoniae; Categorical agreement; Major error; Modified disk diffusion; Tigecycline; Very major error.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Acinetobacter Infections / microbiology
  • Acinetobacter baumannii / drug effects*
  • Acinetobacter baumannii / growth & development
  • Anti-Bacterial Agents / pharmacology*
  • Carbapenems / pharmacology
  • China
  • Disk Diffusion Antimicrobial Tests / methods*
  • Drug Resistance, Bacterial*
  • Humans
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / drug effects*
  • Klebsiella pneumoniae / growth & development
  • Microbial Sensitivity Tests / methods*
  • Tigecycline / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Tigecycline